| 12 | Adenosine Triphosphate (ATP)IBA
05/2004
-
01/2000 |
| 5 | Opioid Analgesics (Opioids)IBA
03/2007
-
08/2000 |
| 5 | Opioid Receptors (Opioid Receptor)IBA
02/2005
-
05/2001 |
| 5 | KATP ChannelsIBA
11/2003
-
06/2000 |
| 4 | TAN 67IBA
08/2001
-
08/2000 |
| 4 | triphenyltetrazoliumIBA
03/2001
-
05/2000 |
| 3 | CytokinesIBA
03/2007
-
07/2000 |
| 3 | mu Opioid Receptors (mu Opioid Receptor)IBA
02/2005
-
09/2001 |
| 3 | D-Penicillamine (2,5)- EnkephalinIBA
07/2004
-
07/2003 |
| 3 | tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA
11/2003
-
09/2001 |
| 3 | delta Opioid Receptors (delta Opioid Receptor)IBA
07/2003
-
03/2001 |
| 3 | Narcotic Antagonists (Opioid Antagonists)IBA
01/2003
-
02/2001 |
| 3 | BIIB 513IBA
12/2001
-
05/2000 |
| 3 | HMR 1098IBA
05/2001
-
06/2000 |
| 3 | mitochondrial K(ATP) channelIBA
04/2001
-
08/2000 |
| 3 | Pharmaceutical PreparationsIBA
02/2001
-
05/2000 |
| 3 | Glyburide (Glibenclamide)FDA LinkGeneric
11/2000
-
06/2000 |
| 2 | CalciumIBA
06/2011
-
08/2010 |
| 2 | KetamineFDA LinkGeneric
07/2005
-
02/2005 |
| 2 | Thr(6)- Leu(5) Ser(2) enkephalinIBA
07/2003
-
10/2002 |
| 2 | ChloridesIBA
09/2001
-
04/2001 |
| 2 | Sodium-Hydrogen ExchangersIBA
09/2001
-
05/2000 |
| 2 | EnzymesIBA
05/2001
-
04/2000 |
| 1 | Chloride Channels (Chloride Channel)IBA
11/2011 |
| 1 | Anti-Arrhythmia AgentsIBA
11/2011 |
| 1 | Ion Channels (Ion Channel)IBA
11/2011 |
| 1 | Isoproterenol (Isoprenaline)FDA LinkGeneric
11/2011 |
| 1 | Digoxin (Digitek)FDA LinkGeneric
06/2011 |
| 1 | Risedronic Acid (Actonel)FDA LinkGeneric
08/2010 |
| 1 | Vitamin DFDA LinkGeneric
08/2010 |
| 1 | Adenosine KinaseIBA
07/2005 |
| 1 | kappa(2) opioid receptorIBA
07/2005 |
| 1 | Purinergic P1 Receptors (Adenosine Receptor)IBA
07/2005 |
| 1 | 5-iodotubercidinIBA
07/2005 |
| 1 | 1,3-dipropyl-8-cyclopentylxanthineIBA
07/2005 |
| 1 | kappa Opioid Receptors (kappa Opioid Receptor)IBA
02/2005 |
| 1 | SolutionsIBA
07/2004 |
| 1 | BMS 180448IBA
05/2004 |
| 1 | RimonabantIBA
01/2004 |
| 1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2004 |
| 1 | anandamide (arachidonylethanolamide)IBA
01/2004 |
| 1 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2004 |
| 1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2004 |
| 1 | ORALIT (ORS)IBA
11/2003 |
| 1 | Potassium Channels (Potassium Channel)IBA
11/2003 |
| 1 | tyrosyl- tetrahydroisoquinolinecarbonyl- psi(methylamino)phenylalanyl- phenylalanineIBA
01/2003 |
| 1 | benzamideIBA
12/2001 |
| 1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2001 |
| 1 | Creatine Kinase (Creatine Phosphokinase)IBA
09/2001 |
| 1 | Phosphotransferases (Kinase)IBA
09/2001 |
| 1 | isoquinolineIBA
09/2001 |
| 1 | 2- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA
09/2001 |
| 1 | Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA
09/2001 |
| 1 | AntioxidantsIBA
08/2001 |
| 1 | Glycine (Aminoacetic Acid)FDA LinkGeneric
08/2001 |
| 1 | CeramidasesIBA
05/2001 |
| 1 | CeramidesIBA
05/2001 |
| 1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2001 |
| 1 | 20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
05/2001 |
| 1 | 14,15-dihydroxyeicosatrienoic acidIBA
05/2001 |
| 1 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
05/2001 |
| 1 | Arachidonic Acid (Vitamin F)IBA
05/2001 |
| 1 | Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2001 |
| 1 | Protein Kinase CIBA
03/2001 |
| 1 | Proteins (Proteins, Gene)FDA Link
03/2001 |
| 1 | Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA
03/2001 |
| 1 | 7-benzylidenenaltrexoneIBA
02/2001 |
| 1 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2001 |
| 1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2001 |
| 1 | Naloxone (Narcan)FDA LinkGeneric
02/2001 |
| 1 | ElementsIBA
01/2001 |
| 1 | 5-hydroxydecanoic acidIBA
11/2000 |
| 1 | PotassiumIBA
08/2000 |